RT @UCLPsychiatry: Congrats to our DoP colleagues on their 2024–25 promotions (effective 01 October 2025)! 🌟 . 👏@GemmaLewis13 Prof of Psych….

RT @Rational_Psych: In February, I saw @michaelbrowni19 present the results of PAX-D, a randomised controlled trial of pramipexole in treat….

RT @Harry_Costello: Medicine and #psychiatry in this country changed significantly today. Let’s hope this shift doesn’t come at the cost o….

RT @Matt_Nour: 🚨 Job adverts LIVE! 🚨. We want to understand how the brain supports abstract cognition in psychosis, using cutting-edge neur….

@pSelvaggi @otta_dps @bkstatton @m_wall . #psychopharmacology #neuroimaging #MRI #psychiatry.

… is one way to get around that. Which is what we did — with the first study of this kind to give more than a one-off dose (and the first to study a D2/3 partial agonist) to healthy volunteers. Full text available here:

Studies have reported mixed results re the effect of antipsychotics on brain (including striatal) volumes in people with psychosis. One reason for this is likely to be confounding by indication. Looking at the effects of antipsychotics on the brain in healthy volunteers ….

🚨New paper day! 🚨. Led by the super @pSelvaggi, we found that one week of (barely) treatment dose amisulpride or aripiprazole led to reversible increases in striatal volumes on MRI in healthy volunteers 👇 . Why does this matter?? … …

RT @SimonWNeuro: 🚨 Delighted to announce our group's latest publication. We developed an AI model to automatically recognise operative wo….

RT @Harry_Costello: Delighted our (@jonroiser @ProfRobHoward @a_schrag @ymyymmr @karelkieslich) paper is now out in @Brain1878! 🎉. We show….

Show me a punchier article title, I’ll wait….

. see our open access paper for details!. Huge thanks, as ever, to the dozens of subjects who took part, without whom this work would not have been possible. @m_wall @_ecologos @rob_mccutcheon . #fMRI #MRI #neuropsychopharmacology #psychopharmacology #psychiatry.

. D2/3 blockade (#amisulpride) and/or partial agonism (#aripiprazole) cause negative symptoms, motor dysfunction or impaired #striatal #reward activity in healthy volunteers. We found interesting differences between these commonly prescribed medications . 2/3.

Very happy to see this work - led by friend and colleague Dr Martin Osugo - #published in @NatureComms at the end of last week. In brief: we ran a double-blind, placebo-controlled, crossover design, #neuroimaging study, to examine whether . 1/3.

Who cares about the score anyway @Harry_Costello #PUP

RT @NC_Renic: "we apologize for the short delay"

RT @aemonten: Yeah. Not good.

RT @susie_dent: Word of the day is ‘recrudescence’ (17th century): the return of something terrible after a time of reprieve.

RT @Keith_Laws: Understanding variability: the role of meta-analysis of variance.Makes important point about the in….

We call for a ��thorough QT” (#TQT) study of aripiprazole, as has been undertaken for some other #antipsychotics. Until this is completed, we advocate closer ECG monitoring of patients on, or due to start, aripiprazole 🩺. @UCLPsychiatry @KingsIoPPN @MRC_LMS #psychopharmacology.